Various Diseases Pipeline Product Landscape Reviewed in In-demand Reports by Global Markets Direct Published at

28 Apr 2015 • by Natalie Aster

LONDON – Market Publishers Ltd announces that in-demand Global Markets Direct reports on the pipeline products for different diseases have been added to its catalogue.

The research reports canvass the therapeutic pipelines for the variety of diseases, providing comparative analyses of pipeline drugs that are in different stages of development; assessments for different therapeutic products by drug target, MoA, RoA and molecule kind. Each research publication offers up-to-the-minute data on the most remarkable pipeline projects, scrutinises the competitive landscap, besides thoroughly examining the dominant market players. Furthermore, accurate insights into late stage and discontinued projects are provided, as is information on freshest updates, topical news and press releases pertaining to pipeline products.

Pipelines Reviews List Includes But Is Not Limited to:

Reasons to Buy:

  • Gain access to essential competitor information, granular analysis, and keen insights to devise effective R&D strategies.
  • Find out about the emerging players with strong portfolios of products and elaborate efficient counterstrategies to obtain a competitive edge.
  • Develop strategic initiatives by comprehending key companies’ focus areas.
  • Identify and discern important and versatile therapeutics types being currently developed for the pertinent disorder.
  • Effectively plan M&As by identifying dominant players with the most promising drugs in the pipeline.
  • Comprehend the pertinent pipeline’s depth and the respective indication therapeutics’ focus.
  • Identify the partners with the most interesting projects to improve your business.
  • Adjust the therapeutic portfolio by detecting discontinued projects and factors that have driven them away from the pipeline.

More in-demand and new reports by the publisher can be found at Global Markets Direct page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970